ARCHIVES

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

Funding Opportunities.

June 28, 2002